ESMO Media Releases

An updated version of the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) will enable users to evaluate single-arm studies for the first time.

The optimal follow-up protocol for patients with completely resected non-small cell lung cancer (NSCLC) remains elusive after results of the IFCT-0302 trial, presented at the ESMO 2017 Congress in Madrid (1), did not show a difference in overall survival (OS) between patients who received computed tomography (CT) scans as part of their follow-up, and those who did not.

Abstracts accepted as oral presentations and posters at the ESMO 2017 Congress will be published online at 00:05 CEST on 31 August 2017. 

ESMO 2017 is once again the place to be for breaking news on cancer research. ESMO 2017, the annual oncology congress organised by the European Society for Medical Oncology (ESMO) in partnership with the European Association for Cancer Research (EACR) will take place in Madrid, Spain, from 8 to 12 September at IFEMA, Feria de Madrid.

Three leading European organisations in the fight against cancer have called the EU to urgently increase its support for independent academic research for the benefit of cancer patients, in an article published today in ESMO Open.

The European Society for Medical Oncology (ESMO), the leading professional organisation for medical oncology, has announced the recipients of its four distinguished annual awards, to be presented at the ESMO 2017 Congress (8-12 September, Madrid, Spain).

For patients with colorectal cancer that has metastasised to the liver, having a primary tumour on the left side, as opposed to the right side of the colon, is known to be a significant advantage in terms of treatment response.

A new study shows that so-called “liquid biopsies” may not only sound an early alert that a treatment’s effect is diminishing, but may also help explain why -sometimes offering clues about what to do next.

The benefits of a “Mediterranean diet” (MD) are well-known when it comes to colorectal protection, but it’s hard to know specifically what elements of the diet are the healthiest.

ESMO announced today that the President for 2020-2021 is Professor Solange Peters, MD, PhD, head of the Medical Oncology Service, Chair of Thoracic Oncology, Oncology Department, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

The Impact Factor for Annals of Oncology has risen to 11.855, according to the latest Journal Citation Reports®* (1).  The journal now sits 10th in the field, within the top 5% of oncology titles.

Around 3,500 oncology professionals and researchers from around the world will learn about the latest advances in the field at the 19^th ESMO World Congress on Gastrointestinal Cancer taking place in Barcelona, Spain, from 28 June to 1 July 2017